CClinicalTrials.gg
Status unknownNCT05682105Updated Jan 12, 2023

Detection of Jaundice From Ocular Images Via Deep Learning

An observational study in Ophthalmology, Artificial Intelligence and Hepatobiliary Disease, sponsored by Sun Yat-sen University. Status unknown at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-12.

Sponsored by Sun Yat-sen University · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,633
Ages
18 Years and older
Sex
All
01

Study summary

Our study presents a detection model predicting a diagnosis of jaundice (clinical jaundice and occult jaundice) trained on prospective cohort data from slit-lamp photos and smartphone photos, demonstrating the model's validity and assisting clinical workers in identifying patient underlying hepatobiliary diseases.

Read the detailed description

This study demonstrated that deep learning models could detect jaundice using ocular images in blood levels with reasonable accuracy, providing a non-invasive method for jaundice detection and recognition. This algorithm can assist clinical surgeons with daily follow-up visits and provide referral advice. It also highlights the algorithm's potential smartphone application in sizeable real-world population-based disease-detecting or telemedicine programs.

02

Conditions studied

  • Ophthalmology
  • Artificial Intelligence
  • Hepatobiliary Disease

Keywords

  • Ophthalmology
  • Artificial Intelligence
  • ocualr image
  • Jaundice
03

In context

Digestive System Diseases

613 studies on the registry are indexed under Digestive System Diseases; 117 are open to participants now.

This study's enrollment of 1,633 is above the median of 272 across 193 observational studies indexed under Digestive System Diseases.

Browse Digestive System Diseases studies →

Lead sponsor

Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

This prospective, multicentre, observational study was led by Zhongshan Ophthalmic Centre (ZOC), Sun Yat-sen University, and conducted in three phases to collect data from participants from three surgery departments and three medical examination centres, including the Department of Hepatobiliary Surgery of the Third Affiliated Hospital of Sun Yat-sen University (HTH; Guangzhou, China), the Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University (ITH; Guangzhou, China), the Department of Infectious Diseases, the Affiliated Huadu Hospital of Southern Medical University (HDH; Guangzhou, China), the Medical Centre of the Third Affiliated Hospital of Sun Yat-sen University(MCH; Guangzhou, China), Nantian Medical Centre of Aikang Health Care (NMC), and Huanshidong Medical Centre of Aikang Health Care (HMC).

Inclusion criteria

  • The quality of slit-lamp images should be clinical acceptable. More than 90% of the slit-lamp image area, including three central regions (sclera, pupil, and lens) are easy to read and discriminate.

Exclusion criteria

Exclusion Criteria:

  • Images with light leakage (>10% of the area), spots from lens flares or stains, and overexposure were excluded from further analysis
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,633 participants (actual)
Patient registry
No

Groups and cohorts

  • Development dataset

    Slit-lamp images collected from the Department of Hepatobiliary Surgery of the Third Affiliated Hospital of Sun Yat-sen University(HTH), Affiliated Huadu Hospital of Southern Medical University(HDH), and Nantian Medical Centre of Aikang Health Care (NMC).

  • Testing dataset

    Slit-lamp and smartphone images collected from the Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University(ITH), Huanshidong Medical Centre of Aikang Health Care, the Medical Centre of the Third Affiliated Hospital of Sun Yat-sen University(MCH).

06

What researchers measure

Primary outcomes

  1. area under the receiver operating characteristic curve of the deep learning system

    The investigators will calculate the area under the receiver operating characteristic curve of deep learning system

    Time frame: baseline

Secondary outcomes

  1. sensitivity and specificity of the deep learning system

    The investigators will calculate the sensitivity and specifity of deep learning system

    Time frame: baseline

07

Study locations

1 site
  • Zhongshan Ophthalmic Center
    Guangzhou, Guangdong 510000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05682105
Lead sponsor
Sun Yat-sen University
Collaborators
Third Affiliated Hospital, Sun Yat-Sen University, Affiliated Huadu Hospital of Southern Medical University, Aikang Health Care
Responsible party
Haotian Lin (Principal Investigator, Sun Yat-sen University) — Principal investigator
First posted
Jan 12, 2023
Start date
Dec 1, 2018
Primary completion
Oct 30, 2022
Completion
Jun 30, 2023 (estimated)
Last update
Jan 12, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion